CSPC PHARMACEUTICAL GROUP LIMIT - stock earnings
CSPCY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 209.4 million USD | 1.1 billion USD |
| 2023Q2 | 212.3 million USD | 1.1 billion USD |
| 2023Q1 | 208.3 million USD | 1.2 billion USD |
| 2022Q4 | 235.6 million USD | 1.1 billion USD |
| 2022Q3 | 211.3 million USD | 1.1 billion USD |
| 2022Q2 | 233.3 million USD | 1.2 billion USD |
| 2022Q1 | 221.2 million USD | 1.2 billion USD |
| 2017Q4 | 111.4 million USD | 652.2 million USD |
| 2017Q3 | 109.8 million USD | 601.9 million USD |
| 2017Q2 | 99.6 million USD | 550.4 million USD |
| 2017Q1 | 92.7 million USD | 504.5 million USD |
CSPCY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 864.3 million USD | 4.4 billion USD |
| 2022 | 884.1 million USD | 4.5 billion USD |
| 2021 | 882.2 million USD | 4.4 billion USD |
| 2020 | 789.8 million USD | 3.8 billion USD |
| 2019 | 532.2 million USD | 3.2 billion USD |
| 2018 | 467.2 million USD | 2.7 billion USD |
| 2017 | 354.9 million USD | 2.0 billion USD |
| 2016 | 270.9 million USD | 1.6 billion USD |
| 2015 | 215.2 million USD | 1.5 billion USD |
| 2014 | 163.8 million USD | 1.4 billion USD |
| 2013 | 125.6 million USD | 1.3 billion USD |
| 2012 | 279.2 million USD | 535.4 million USD |
| 2011 | 29.9 million USD | 946.7 million USD |
| 2010 | 97.5 million USD | 1.0 billion USD |
| 2009 | 127.2 million USD | 921.1 million USD |
| 2008 | 121.4 million USD | 881.3 million USD |
| 2007 | 60.8 million USD | 635.8 million USD |
| 2006 | 2.0 million USD | 455.4 million USD |
| 2005 | 20.2 million USD | 412.6 million USD |
| 2004 | 31.5 million USD | 315.5 million USD |
| 2003 | 67.2 million USD | 331.2 million USD |
CSPCY
Price: $3.38
Dividend Yield: 0.07%
Forward Dividend Yield: 4.24%
Payout Ratio: 53.02%
Dividend Per Share: 0.14 USD
Earnings Per Share: 0.27 USD
P/E Ratio: 10.10
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 10.3 billion
Average Dividend Frequency: 2
Years Paying Dividends: 6
DGR3: 26.19%